[1]
|
McDermott, K., Fang, M., Boulton, A.J.M., Selvin, E. and Hicks, C.W. (2023) Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care, 46, 209-221. https://doi.org/10.2337/dci22-0043
|
[2]
|
Hinchliffe, R.J., Forsythe, R.O., Apelqvist, J., et al. (2020) Guidelines on Diagnosis, Prognosis, and Management of Peripheral Artery Disease in Patients with Foot Ulcers and Diabetes (IWGDF 2019 Update). Diabetes/Metabolism Research and Reviews, 36, e3276. https://doi.org/10.1002/dmrr.3276
|
[3]
|
Graziani, L., Silvestro, A., Bertone, V., et al. (2007) Vascular Involvement in Diabetic Subjects with Ischemic Foot Ulcer: A New Morphologic Categorization of Disease Severity. European Journal of Vascular and Endovascular Surgery, 33, 453-460. https://doi.org/10.1016/j.ejvs.2006.11.022
|
[4]
|
Narula, N., Dannenberg, A.J., Olin, J.W., et al. (2018) Pathology of Peripheral Artery Disease in Patients with Critical Limb Ischemia. Journal of the American College of Cardiology, 72, 2152-2163.
https://doi.org/10.1016/j.jacc.2018.08.002
|
[5]
|
Taylor, G.I. and Palmer, J.H. (1987) The Vascular Territories (An-giosomes) of the Body: Experimental Study and Clinical Applications. British Journal of Plastic Surgery, 40, 113-141. https://doi.org/10.1016/0007-1226(87)90185-8
|
[6]
|
Jongsma, H., Bekken, J.A., Akkersdijk, G.P., Hoeks, S.E., Verhagen, H.J. and Fioole, B. (2017) Angiosome-Directed Revascularization in Patients with Critical Limb Ischemia. Journal of Vascular Surgery, 65, 1208-1219.e1.
https://doi.org/10.1016/j.jvs.2016.10.100
|
[7]
|
Chuter, V., Schaper, N., Mills, J., et al. (2023) Effectiveness of Re-vascularisation for the Ulcerated Foot in Patients with Diabetes and Peripheral Artery Disease: A Systematic Review. Diabetes/Metabolism Research and Reviews, e3700. https://doi.org/10.1002/dmrr.3700
|
[8]
|
Kurianov, P., Lipin, A., Antropov, A., et al. (2022) Propensity-Matched Analysis Does Not Support Angiosome-Guided Revascularization of Multilevel Peripheral Artery Disease (PAD). Vascular Medicine, 27, 47-54.
https://doi.org/10.1177/1358863X211038627
|
[9]
|
Settembre, N., Biancari, F., Spillerova, K., Albäck, A., Söder-ström, M. and Venermo, M. (2020) Competing Risk Analysis of the Impact of Pedal Arch Status and Angio-some-Targeted Revascularization in Chronic Limb-Threatening Ischemia. Annals of Vascular Surgery, 68, 384-390. https://doi.org/10.1016/j.avsg.2020.03.042
|
[10]
|
Choke, E., Tang, T.Y., Cheng, S.C. and Tay, J.S. (2020) Treatment of Lower Limb Ischaemia in Patients with Diabetes. Diabetes/Metabolism Research and Reviews, 36, e3262. https://doi.org/10.1002/dmrr.3262
|
[11]
|
Caradu, C., Lakhlifi, E., Colacchio, E.C., et al. (2019) Systematic Review and Updated Meta-Analysis of the Use of Drug-Coated Balloon Angioplasty versus Plain Old Balloon Angioplasty for Femoropopliteal Arterial Disease. Journal of Vascular Surgery, 70, 981-995.e10. https://doi.org/10.1016/j.jvs.2019.01.080
|
[12]
|
Lammer, J., Zeller, T., Hausegger, K.A., et al. (2013) Hepa-rin-Bonded Covered Stents versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis with PROPATEN Bioactive Surface [VIA] versus Bare Nitinol Stent in the Treatment of Long Lesions in Superficial Femoral Artery Occlusive Disease). Journal of the American College of Cardi-ology, 62, 1320-1327.
https://doi.org/10.1016/j.jacc.2013.05.079
|
[13]
|
Mwipatayi, B.P., Ouriel, K., Anwari, T., et al. (2020) A Systematic Review of Covered Balloon-Expandable Stents for Treating Aortoiliac Occlusive Disease. Journal of Vascular Surgery, 72, 1473-1486.e2.
https://doi.org/10.1016/j.jvs.2020.01.084
|
[14]
|
Ohki, T., Kichikawa, K., Yokoi, H., et al. (2021) Long-Term Results of the Japanese Multicenter Viabahn Trial of Heparin Bonded Endovascular Stent Grafts for Long and Complex Lesions in the Superficial Femoral Artery. Journal of Vascular Surgery, 74, 1958-1967.e2. https://doi.org/10.1016/j.jvs.2021.05.056
|
[15]
|
Geraghty, P.J., Mewissen, M.W., Jaff, M.R., Ansel, G.M. and VIBRANT Investigators (2013) Three-Year Results of the VIBRANT Trial of VIABAHN Endoprosthesis versus Bare Nitinol Stent Implantation for Complex Superficial Femoral Artery Occlusive Disease. Journal of Vascular Surgery, 58, 386-395.e4.
https://doi.org/10.1016/j.jvs.2013.01.050
|
[16]
|
Ichihashi, S., Takahara, M., Iida, O., et al. (2021) Clinical Impact of Stent Graft Thrombosis in Femoropopliteal Arterial Lesions. JACC: Cardiovascular Interventions, 14, 1137-1147. https://doi.org/10.1016/j.jcin.2021.03.030
|
[17]
|
Krankenberg, H., Zeller, T., Ingwersen, M., et al. (2017) Self-Expanding versus Balloon-Expandable Stents for Iliac Artery Occlusive Disease: The Randomized ICE Trial. JACC: Cardiovascular Interventions, 10, 1694-1704.
https://doi.org/10.1016/j.jcin.2017.05.015
|
[18]
|
Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., et al. (2017) 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 135, e726-e779.
https://doi.org/10.1161/CIR.0000000000000502
|
[19]
|
Bradbury, A.W., Adam, D.J., Bell, J., et al. (2010) Multi-centre Randomised Controlled Trial of the Clinical and Cost-Effectiveness of a Bypass-Surgery-First versus a Bal-loon-Angioplasty-First Revascularisation Strategy for Severe Limb Ischaemia Due to Infrainguinal Disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial. Health Technology Assessment, 14. https://doi.org/10.3310/hta14140
|
[20]
|
Almasri, J., Adusumalli, J., Asi, N., et al. (2019) A Systematic Review and Meta-Analysis of Revascularization Outcomes of Infrainguinal Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery, 58, S110-S119. https://doi.org/10.1016/j.ejvs.2019.04.013
|
[21]
|
Bradbury, A.W., Moakes, C.A., Popplewell, M., et al. (2023) A Vein Bypass First versus a Best Endovascular Treatment First Re-vascularisation Strategy for Patients with Chronic Limb Threatening Ischaemia Who Required an Infra-Popliteal, with or without an Additional More Proximal Infra-Inguinal Revascularisation Procedure to Restore Limb Perfusion (BASIL-2): An Open-Label, Randomised, Multicentre, Phase 3 Trial. The Lancet, 401, 1798-1809.
https://doi.org/10.1016/S0140-6736(23)00462-2
|
[22]
|
Farber, A., Menard, M.T., Conte, M.S., et al. (2022) Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. The New England Journal of Medicine, 387, 2305-2316. https://doi.org/10.1056/NEJMoa2207899
|
[23]
|
Peters, F., Behrendt, C.A. and IDOMENEO Collabo-rators (2023) Limb Related Outcomes of Endovascular vs. Open Surgical Revascularisation in Patients with Peripheral Arterial Occlusive Disease: A Report from the Prospective GermanVasc Cohort Study. European Journal of Vascular and Endovascular Surgery, 66, 85-93.
https://doi.org/10.1016/j.ejvs.2023.03.040
|
[24]
|
Nierlich, P., Enzmann, F.K., Metzger, P., et al. (2020) Alternative Venous Conduits for Below Knee Bypass in the Absence of Ipsilateral Great Saphenous Vein. European Journal of Vascular and Endovascular Surgery, 60, 403-409.
https://doi.org/10.1016/j.ejvs.2020.06.016
|
[25]
|
Ho, V.T., Gologorsky, R., Kibrik, P., et al. (2020) Open, Percuta-neous, and Hybrid Deep Venous Arterialization Technique for No-Option Foot Salvage. Journal of Vascular Surgery, 71, 2152-2160.
https://doi.org/10.1016/j.jvs.2019.10.085
|
[26]
|
Schreve, M.A., Minnee, R.C., Bosma, J., Leijdekkers, V.J., Idu, M.M. and Vahl, A.C. (2014) Comparative Study of Venous Arterialization and Pedal Bypass in a Patient Cohort with Critical Limb Ischemia. Annals of Vascular Surgery, 28, 1123-1127. https://doi.org/10.1016/j.avsg.2013.08.010
|
[27]
|
Schreve, M.A., Vos, C.G., Vahl, A.C., et al. (2017) Venous Arte-rialisation for Salvage of Critically Ischaemic Limbs: A Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 53, 387-402.
https://doi.org/10.1016/j.ejvs.2016.11.007
|
[28]
|
Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M. and Karna-batidis, D. (2018) Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 7, e011245.
https://doi.org/10.1161/JAHA.118.011245
|
[29]
|
Amlani, V., Falkenberg, M. and Nordanstig, J. (2021) The Current Status of Drug-Coated Devices in Lower Extremity Peripheral Artery Disease Interventions. Progress in Cardiovascular Diseases, 65, 23-28.
https://doi.org/10.1016/j.pcad.2021.02.002
|
[30]
|
Zeller, T., Brechtel, K., Meyer, D.R., Noory, E., Beschorner, U. and Albrecht, T. (2020) Six-Month Outcomes from the First-in-Human, Single-Arm SELUTION Sus-tained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. Journal of Endovascular Therapy, 27, 683-690. https://doi.org/10.1177/1526602820941811
|
[31]
|
Tang, T.Y., Yap, C., Soon, S.X.Y., et al. (2021) World’s First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study. Journal of Endovascular Therapy, 28, 555-566. https://doi.org/10.1177/15266028211007457
|
[32]
|
Wang, J.L., Qin, Z., Wang, Z.J., et al. (2018) New Predictors of In-Stent Restenosis in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stent. Journal of Geriatric Cardiology, 15, 137-145.
|
[33]
|
Reijnen, M.M.P.J., van Wijck, I., Brodmann, M., et al. (2023) Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis. CardioVascular and Interventional Radiology, 46, 1329-1345.
https://doi.org/10.1007/s00270-023-03478-y
|
[34]
|
Jia, X., Zhang, J., Zhuang, B., et al. (2016) Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence from the AcoArt I Trial. JACC: Cardiovascular Interventions, 9, 1941-1949. https://doi.org/10.1016/j.jcin.2016.06.055
|
[35]
|
Brodmann, M., Moscovic, M., Wang, J.C.C., et al. (2020) Re-al-World Experience with a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III. JACC: Cardiovascular Interventions, 13, 2289-2299. https://doi.org/10.1016/j.jcin.2020.06.059
|
[36]
|
Sachar, R., Soga, Y., Ansari, M.M., et al. (2021) 1-Year Results from the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. JACC: Cardiovascular Interventions, 14, 1123-1133.
https://doi.org/10.1016/j.jcin.2021.03.021
|
[37]
|
Schneider, P.A., Laird, J.R., Tepe, G., et al. (2018) Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial. Circulation: Cardiovascular Interventions, 11, e005891. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006699
|
[38]
|
Rosenfield, K., Jaff, M.R., White, C.J., et al. (2015) Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. The New England Journal of Medicine, 373, 145-153. https://doi.org/10.1056/NEJMoa1406235
|
[39]
|
Krishnan, P., Faries, P., Niazi, K., et al. (2017) Stel-larex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies. Circulation, 136, 1102-1113. https://doi.org/10.1161/CIRCULATIONAHA.117.028893
|
[40]
|
Shishehbor, M.H., Scheinert, D., Jain, A., et al. (2023) Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients with Femoropopliteal Arterial Disease. Journal of the American College of Cardiology, 81, 237-249.
https://doi.org/10.1016/j.jacc.2022.10.016
|
[41]
|
Zeller, T., Micari, A., Scheinert, D., et al. (2020) The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. JACC: Cardiovascular Interventions, 13, 431-443. https://doi.org/10.1016/j.jcin.2019.10.059
|
[42]
|
Liistro, F., Porto, I., Angioli, P., et al. (2013) Drug-Eluting Balloon in Peripheral Intervention for below the Knee Angioplasty Evaluation (DEBATE-BTK): A Randomized Trial in Diabetic Patients with Critical Limb Ischemia. Circulation, 128, 615-621. https://doi.org/10.1161/CIRCULATIONAHA.113.001811
|
[43]
|
Liistro, F., Angioli, P., Ventoruzzo, G., et al. (2020) Randomized Controlled Trial of Acotec Drug-Eluting Balloon versus Plain Balloon for Below-the-Knee Angio-plasty. JACC: Cardiovascular Interventions, 13, 2277-2286.
https://doi.org/10.1016/j.jcin.2020.06.045
|
[44]
|
Ipema, J., et al. (2020) Editor’s Choice-Drug Coated Balloon An-gioplasty vs. Standard Percutaneous Transluminal Angioplasty in below the Knee Peripheral Arterial Disease: A System-atic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 59, 265-275. https://doi.org/10.1016/j.ejvs.2019.10.002
|
[45]
|
Patel, A., Irani, F.G., Pua, U., et al. (2021) Randomized Controlled Trial Comparing Drug-Coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Be-low-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial. Radiology, 300, 715-724. https://doi.org/10.1148/radiol.2021204294
|
[46]
|
Byrne, R.A., Joner, M., Alfonso, F. and Kastrati, A. (2014) Drug-Coated Balloon Therapy in Coronary and Peripheral Artery Disease. Nature Reviews Cardiology, 11, 13-23. https://doi.org/10.1038/nrcardio.2013.165
|
[47]
|
Qamar, S.U.R., Spahić, L., Benolić, L., Zivanovic, M. and Filipović, N. (2023) Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics, 15, Article No. 1813. https://doi.org/10.3390/pharmaceutics15071813
|
[48]
|
Fanelli, F., Cannavale, A., Gazzetti, M., et al. (2014) Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial Disease. CardioVascular and Interven-tional Radiology, 37, 898-907.
https://doi.org/10.1007/s00270-014-0904-3
|
[49]
|
Dake, M.D., Ansel, G.M., Jaff, M.R., et al. (2016) Durable Clin-ical Effectiveness with Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Ran-domized Trial. Circulation, 133, 1472-1483.
https://doi.org/10.1161/CIRCULATIONAHA.115.016900
|
[50]
|
Liistro, F., Angioli, P., Porto, I., et al. (2019) Drug-Eluting Balloon versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study. Journal of the American College of Cardiology, 74, 205-215.
https://doi.org/10.1016/j.jacc.2019.04.057
|
[51]
|
Bausback, Y., Wittig, T., Schmidt, A., et al. (2019) Drug-Eluting Stent versus Drug-Coated Balloon Revascularization in Patients with Femoropopliteal Arterial Disease. Journal of the American College of Cardiology, 73, 667-679.
https://doi.org/10.1016/j.jacc.2018.11.039
|
[52]
|
Tsujimura, T., Takahara, M., Iida, O., et al. (2021) Clinical Out-comes of Polymer-Free, Paclitaxel-Coated Stents vs Stent Grafts in Peripheral Arterial Disease Patients with Femoropop-liteal Artery Lesions. Journal of Vascular Surgery, 73, 1998-2008.e1. https://doi.org/10.1016/j.jvs.2020.12.061
|
[53]
|
Haine, A., Schmid, M.J., Schindewolf, M., et al. (2019) Comparison between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. European Journal of Vascular and Endovascular Surgery, 58, 865-873. https://doi.org/10.1016/j.ejvs.2019.09.002
|
[54]
|
Müller-Hülsbeck, S. (2016) EluviaTM Peripheral Stent System for the Treatment of Peripheral Lesions above the Knee. Expert Opinion on Drug Delivery, 13, 1639-1644. https://doi.org/10.1080/17425247.2016.1230098
|
[55]
|
Kum, S., Ipema, J., Huizing, E., et al. (2021) Outcomes of the Paclitaxel-Eluting Eluvia Stent for Long Femoropopliteal Lesions in Asian Patients with Predominantly Chronic Limb-Threatening Ischemia. Vascular Medicine, 26, 267-272.
https://doi.org/10.1177/1358863X20987894
|
[56]
|
Stavroulakis, K., Torsello, G., Bosiers, M., Argyriou, A., Tsilimparis, N. and Bisdas, T. (2021) 2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions. JACC: Cardiovascular Interventions, 14, 692-701. https://doi.org/10.1016/j.jcin.2021.01.026
|
[57]
|
Ichihashi, S., Takahara, M., Yamaoka, T., et al. (2022) Drug Eluting versus Covered Stent for Femoropopliteal Artery Lesions: Results of the ULTIMATE Study. European Journal of Vas-cular and Endovascular Surgery, 64, 359-366.
https://doi.org/10.1016/j.ejvs.2022.05.046
|
[58]
|
Gouëffic, Y., Torsello, G., Zeller, T., et al. (2022) Efficacy of a Drug-Eluting Stent versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Re-sults of the EMINENT Randomized Trial. Circulation, 146, 1564-1576. https://doi.org/10.1161/CIRCULATIONAHA.122.059606
|
[59]
|
Soga, Y., Fujihara, M., Tomoi, Y., et al. (2020) One-Year Late Lumen Loss between a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitax-el-Coated Stent (Zilver PTX) for Femoropopliteal Disease. Journal of Atherosclerosis and Thrombosis, 27, 164-171. https://doi.org/10.5551/jat.50369
|
[60]
|
Gray, W.A., Keirse, K., Soga, Y., et al. (2018) A Polymer-Coated, Paclitax-el-Eluting Stent (Eluvia) versus a Polymer-Free, Paclitaxel-Coated Stent (Zilver PTX) for Endovascular Femoropopliteal Intervention (IMPERIAL): A Randomised, Non-Inferiority Trial. The Lancet, 392, 1541-1551. https://doi.org/10.1016/S0140-6736(18)32262-1
|
[61]
|
Nagatomi, S., Takahara, M., Nakai, T., et al. (2023) Com-paring the Impact of the Loss of Patency between Treatment with Drug-Coated Balloon Angioplasty and Drug-Eluting Stent Placement. Journal of Vascular Surgery, 77, 1751-1759.
https://doi.org/10.1016/j.jvs.2023.01.207
|
[62]
|
Steiner, S., Honton, B., Langhoff, R., et al. (2022) 2-Year Results with a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study. JACC: Cardiovascular Interventions, 15, 618-626.
https://doi.org/10.1016/j.jcin.2021.12.034
|
[63]
|
Spreen, M.I., Martens, J.M., Knippenberg, B., et al. (2017) Long-Term Follow-Up of the PADI Trial: Percutaneous Transluminal Angioplasty versus Drug-Eluting Stents for In-frapopliteal Lesions in Critical Limb Ischemia. Journal of the American Heart Association, 6, e004877. https://doi.org/10.1161/JAHA.116.004877
|
[64]
|
Spreen, M.I., Martens, J.M., Hansen, B.E., et al. (2016) Percuta-neous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Circulation: Cardiovascular Interventions, 9, e002376.
|
[65]
|
Siablis, D., Kitrou, P.M., Spiliopoulos, S., Katsanos, K. and Karnabatidis, D. (2014) Paclitaxel-Coated Balloon Angioplasty versus Drug-Eluting Stenting for the Treatment of Infrapopliteal Long-Segment Arterial Occlusive Disease: The IDEAS Randomized Controlled Trial. JACC: Cardiovas-cular Interventions, 7, 1048-1056.
https://doi.org/10.1016/j.jcin.2014.04.015
|
[66]
|
Scheinert, D., Katsanos, K., Zeller, T., et al. (2012) A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting with the Sirolimus-Eluting Stent in Patients with Ischemic Peripheral Arterial Disease: 1-Year Results from the ACHILLES Trial. Journal of the American College of Cardiology, 60, 2290-2295.
https://doi.org/10.1016/j.jacc.2012.08.989
|
[67]
|
Rastan, A., Tepe, G., Krankenberg, H., et al. (2011) Siroli-mus-Eluting Stents vs. Bare-Metal Stents for Treatment of Focal Lesions in Infrapopliteal Arteries: A Double-Blind, Multi-Centre, Randomized Clinical Trial. European Heart Journal, 32, 2274-2281. https://doi.org/10.1093/eurheartj/ehr144
|
[68]
|
Bosiers, M., Scheinert, D., Peeters, P., et al. (2012) Randomized Comparison of Everolimus-Eluting versus Bare-Metal Stents in Patients with Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease. Journal of Vascular Surgery, 55, 390-398. https://doi.org/10.1016/j.jvs.2011.07.099
|
[69]
|
Fong, K.Y., Xin, L., Ng, J., Loh, S.E.K., Ng, J.J. and Choong, A.M.T.L. (2023) A Systematic Review and Meta-Analysis of Sirolimus-Eluting Stents for Treatment of Below-the-Knee Arterial Disease. Journal of Vascular Surgery, 77, 1264-1273.e3. https://doi.org/10.1016/j.jvs.2022.09.022
|
[70]
|
Fusaro, M., Cassese, S., Ndrepepa, G., et al. (2013) Drug-Eluting Stents for Revascularization of Infrapopliteal Arteries: Updated Meta-Analysis of Randomized Trials. JACC: Cardiovas-cular Interventions, 6, 1284-1293.
https://doi.org/10.1016/j.jcin.2013.08.007
|
[71]
|
Katsanos, K., Spiliopoulos, S., Diamantopoulos, A., Karnabatidis, D., Sabharwal, T. and Siablis, D. (2013) Systematic Review of Infrapopliteal Drug-Eluting Stents: A Meta-Analysis of Randomized Controlled Trials. CardioVascular and Interventional Radiology, 36, 645-658. https://doi.org/10.1007/s00270-013-0578-2
|
[72]
|
Liu, X., Zheng, G. and Wen, S. (2017) Drug-Eluting Stents ver-sus Control Therapy in the Infrapopliteal Disease: A Meta-Analysis of Eight Randomized Controlled Trials and Two Cohort Studies. International Journal of Surgery, 44, 166-175. https://doi.org/10.1016/j.ijsu.2017.06.075
|
[73]
|
Nakama, T., Takahara, M., Iwata, Y., et al. (2022) 1-Year Out-comes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions: CAULIFLOWER Study Results. JACC: Cardiovascular Interventions, 15, 1453-1463. https://doi.org/10.1016/j.jcin.2022.03.010
|
[74]
|
Kuo, T.T., Chen, P.L., Huang, C.Y., Lee, C.Y., Shih, C.C. and Chen, I.M. (2019) Outcome of Drug-Eluting Balloon Angioplasty versus Endarterectomy in Common Femoral Artery Occlusive Disease. Journal of Vascular Surgery, 69, 141-147. https://doi.org/10.1016/j.jvs.2018.05.225
|
[75]
|
Saucy, F., Probst, H. and Trunfio, R. (2020) Vessel Preparation Is Essential to Optimize Endovascular Therapy of Infrainguinal Lesions. Frontiers in Cardiovascular Medicine, 7, Article ID: 558129.
https://doi.org/10.3389/fcvm.2020.558129
|
[76]
|
Mustapha, J.A., Lansky, A., Shishehbor, M., et al. (2018) A Pro-spective, Multi-Center Study of the Chocolate Balloon in Femoropopliteal Peripheral Artery Disease: The Chocolate BAR Registry. Catheterization and Cardiovascular Interventions, 91, 1144-1148. https://doi.org/10.1002/ccd.27565
|
[77]
|
Shimada, Y., Kino, N., Tonomura, D., et al. (2019) Efficacy of Cutting Balloon Angioplasty for Chronic Total Occlusion of Femoropopliteal Arteries. Annals of Vascular Surgery, 58, 91-100. https://doi.org/10.1016/j.avsg.2018.10.056
|
[78]
|
Kronlage, M., Werner, C., Dufner, M., et al. (2020) Long-Term Outcome upon Treatment of Calcified Lesions of the Lower Limb Using Scoring Angioplasty Balloon (AngioSculptTM). Clinical Research in Cardiology, 109, 1177-1185.
https://doi.org/10.1007/s00392-020-01610-3
|
[79]
|
Böhme, T., Zeller, T., Shishehbor, M.H., et al. (2023) Chocolate Touch versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study. Journal of Endovascular Therapy.
https://doi.org/10.1177/15266028231179589
|
[80]
|
Scalamogna, M., Kuna, C., Voll, F., et al. (2023) Modified Bal-loons to Prepare Severely Calcified Coronary Lesions before Stent Implantation: A Systematic Review and Me-ta-Analysis of Randomized Trials. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-023-02324-y
|
[81]
|
Giusca, S., Hagstotz, S., Lichtenberg, M., et al. (2022) Phoenix Atherectomy for Patients with Peripheral Artery Disease. EuroIntervention, 18, e432-e442. https://doi.org/10.4244/EIJ-D-21-01070
|
[82]
|
McKinsey, J.F., Zeller, T., Rocha-Singh, K.J., Jaff, M.R., Garcia, L.A. and Definitive Le Investigators (2014) Lower Extremity Revascularization Using Directional Atherectomy: 12-Month Prospective Results of the DEFINITIVE LE Study. JACC: Cardiovascular Interventions, 7, 923-933. https://doi.org/10.1016/j.jcin.2014.05.006
|
[83]
|
Maehara, A., Mintz, G.S., Shimshak, T.M., et al. (2015) Intravas-cular Ultrasound Evaluation of JETSTREAM Atherectomy Removal of Superficial Calcium in Peripheral Arteries. Eu-roIntervention, 11, 96-103.
https://doi.org/10.4244/EIJV11I1A17
|
[84]
|
Rastan, A., Brodmann, M., Böhme, T., et al. (2021) Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial. Circulation: Cardiovascular Interventions, 14, e010280. https://doi.org/10.1161/CIRCINTERVENTIONS.120.010280
|
[85]
|
Wong, C.P., Chan, L.P., Au, D.M., Chan, H.W.C. and Chan, Y.C. (2022) Efficacy and Safety of Intravascular Lithotripsy in Lower Extremity Peripheral Artery Disease: A Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 63, 446-456. https://doi.org/10.1016/j.ejvs.2021.10.035
|
[86]
|
Tepe, G., Brodmann, M., Werner, M., et al. (2021) Intra-vascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes from the Randomized Disrupt PAD III Trial. JACC: Cardiovascular Interventions, 14, 1352-1361.
https://doi.org/10.1016/j.jcin.2021.04.010
|
[87]
|
Clair, D.G., Mustapha, J.A., Shishehbor, M.H., et al. (2021) PROMISE I: Early Feasibility Study of the LimFlow System for Percutaneous Deep Vein Arterialization in No-Option Chronic Limb-Threatening Ischemia: 12-Month Results. Journal of Vascular Surgery, 74, 1626-1635. https://doi.org/10.1016/j.jvs.2021.04.057
|
[88]
|
Schmidt, A., Schreve, M.A., Huizing, E., et al. (2020) Midterm Outcomes of Percutaneous Deep Venous Arterialization with a Dedicated System for Patients with No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study. Journal of Endovascular Therapy, 27, 658-665. https://doi.org/10.1177/1526602820922179
|
[89]
|
Shishehbor, M.H., Powell, R.J., Montero-Baker, M.F., et al. (2023) Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. The New England Journal of Medicine, 388, 1171-1180.
https://doi.org/10.1056/NEJMoa2212754
|
[90]
|
Beshchasna, N., Saqib, M., Kraskiewicz, H., et al. (2020) Recent Advances in Manufacturing Innovative Stents. Pharmaceutics, 12, Article No. 349. https://doi.org/10.3390/pharmaceutics12040349
|
[91]
|
Varcoe, R.L., Schouten, O., Thomas, S.D. and Lennox, A.F. (2016) Experience with the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries below the Knee: 12-Month Clinical and Imaging Outcomes. JACC: Cardiovascular Interventions, 9, 1721-1728. https://doi.org/10.1016/j.jcin.2016.06.005
|